JAZZ
NASDAQ · Pharmaceuticals
Jazz Pharmaceuticals Plc
$225.79
-1.17 (-0.52%)
Performance
1D
—
1W
—
1M
—
3M
+36.32%
6M
+65.16%
1Y
+117.99%
YTD
+30.40%
Open$228.73
Previous Close$226.96
Day High$230.00
Day Low$223.34
52W High$230.40
52W Low$97.50
Volume—
Avg Volume978.9K
Market Cap14.17B
P/E Ratio—
EPS$-5.85
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$167.39
Above
SMA 200
$136.05
Above
RSI (14)
68.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
-17.5% upside
Current
$225.79
$225.79
Target
$186.25
$186.25
$114.97
$186.25 avg
$267.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.39B | 4.17B | 1.73B |
| Net Income | -366,530,233 | -313,392,750 | 500.28M |
| Profit Margin | -8.4% | -7.9% | 28.9% |
| EBITDA | 230.96M | 208.45M | 730.31M |
| Free Cash Flow | — | — | 376.40M |
| Rev Growth | +5.3% | +5.3% | +7.8% |
| Debt/Equity | 1.24 | 1.24 | 0.48 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |